CAGAS
Capital Advisory Group Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-62
| Closed | -$4K | – | 266 |
|
|
2022
Q1 | $4K | Buy |
+62
| New | +$4K | ﹤0.01% | 446 |
|
|
2021
Q4 | – | Sell |
-62
| Closed | -$7K | – | 236 |
|
|
2021
Q3 | $7K | Sell |
62
-186
| -75% | -$21K | ﹤0.01% | 431 |
|
|
2021
Q2 | $40K | Hold |
248
| – | – | 0.01% | 281 |
|
|
2021
Q1 | $30K | Hold |
248
| – | – | 0.01% | 277 |
|
|
2020
Q4 | $38K | Buy |
248
+186
| +300% | +$28.5K | 0.02% | 262 |
|
|
2020
Q3 | $5K | Buy |
+62
| New | +$5K | ﹤0.01% | 377 |
|